Conduit Pharmaceuticals Inc (CDT) concluded trading on Thursday at a closing price of $1.07, with 70.82 million shares of worth about $75.78 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -89.95% during that period and on April 10, 2025 the price saw a gain of about 72.58%. Currently the company’s common shares owned by public are about 9.55M shares, out of which, 8.31M shares are available for trading.
Stock saw a price change of 56.11% in past 5 days and over the past one month there was a price change of -2.73%. Year-to-date (YTD), CDT shares are showing a performance of -84.40% which decreased to -99.66% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.51 but also hit the highest price of $350.00 during that period. The average intraday trading volume for Conduit Pharmaceuticals Inc shares is 3.84 million. The stock is currently trading 29.79% above its 20-day simple moving average (SMA20), while that difference is down -12.41% for SMA50 and it goes to -91.92% lower than SMA200.
Conduit Pharmaceuticals Inc (NASDAQ: CDT) currently have 9.55M outstanding shares and institutions hold larger chunk of about 0.87% of that.
The stock has a current market capitalization of $10.22M and its 3Y-monthly beta is at 2.36. It has posted earnings per share of -$21.28 in the same period. It has Quick Ratio of 0.25. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CDT, volatility over the week remained 29.78% while standing at 20.02% over the month.
